The global Dengue Vaccines Market, valued at US$ 0.4 billion in 2020, is projected to surpass US$ 1.4 billion by 2031, expanding at a compound annual growth rate (CAGR) of 11% from 2021 to 2031. Dengue, a mosquito-borne viral disease caused by four serotypes, affects approximately 390 million people annually, necessitating effective vaccines like Sanofi's Dengvaxia and Takeda's QDENGA. Growth...